Clinical relevance and therapeutic potential of IL-38 in immune and non-immune-related disorders

Interleukin-38 (IL-38) is the most recent member of the IL-1 family that acts as a natural inflammatory inhibitor by binding to cognate receptors, particularly the IL-36 receptor. In vitro, animal and human studies on autoimmune, metabolic, cardiovascular and allergic diseases, as well sepsis and re...

Descripción completa

Detalles Bibliográficos
Autores principales: Haghshenas, Mohammad Reza, Zamir, Mina Roshan, Sadeghi, Mahboubeh, Fattahi, Mohammad Javad, Mirshekari, Kimia, Ghaderi, Abbas
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Libbey Eurotext 2023
Materias:
Review Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10134710/
https://www.ncbi.nlm.nih.gov/pubmed/37052152
http://dx.doi.org/10.1684/ecn.2022.0480

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10134710/
https://www.ncbi.nlm.nih.gov/pubmed/37052152
http://dx.doi.org/10.1684/ecn.2022.0480

Ejemplares similares